Silencing ESCCAL‐1 suppressed ESCC cell invasion, enhanced apoptosis in vitro, and inhibited cancer proliferation by inactivating Src and activating the p38α pathway in the ESCC xenograft mouse model.6, 10. This evidence concerns the gene SRC and esophageal squamous cell carcinoma.